by rss feed | Aug 6, 2023 | biocardia, MSC, MSCs Mesenchymal stem stromal cells, News Feeds, weekly reads
A days ago the news came about Mesoblast not getting FDA approval for its MSC product for GvHD. The MSC area has had a rough few years with various clinical trials including for COVID. The “stem cells for heart disease” arena has also had a tough time....
by rss feed | Jun 29, 2021 | mesenchymal cells, MSCs Mesenchymal stem stromal cells, News Feeds, Wharton's jelly
For more than a year in my first job as a scientist I isolated cells from umbilical cord veins and then tossed the tissue away, never realizing there was more there that could be useful in the form of something called Wharton’s jelly. What’s in this...
by rss feed | Feb 8, 2021 | Blog, mesenchymal cells, mesenchymal stem cells, MSCs, MSCs Mesenchymal stem stromal cells, News Feeds, stromal cells
I confess that I’m old enough to remember when the acronym MSC stood unambiguously for “mesenchymal stem cells”, but should it refer to a broader term like “mesenchymal cells”? The field has moved in that direction. I think that’s...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
